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Abstract
Introduction: Pulmonary talc granulomatosis is a rare disorder characterized by the development
of foreign body granuloma secondary to talc exposure. Previous case reports have documented the
illness in current intravenous drug users who inject medications intended for oral use. We present
a rare case of the disease in a patient with a distant history of heroin abuse who presented initially
with history and imaging findings highly suggestive of malignancy.
Case presentation: A 53-year-old man reported a 4-month history of increasing dyspnea and
weight loss. He had a long history of smoking and admission chest X-ray revealed a density in the
right hemithorax. Computed tomography confirmed a probable mass with further speculated
opacities in both lung fields suspicious for malignant spread. Biopsies obtained using endobronchial
ultrasound-guided aspiration returned negative for malignancy and showed bronchial epithelial cells
with foreign body giant cell reaction and polarizable birefringent talc crystals.
Conclusion: This case demonstrates a rare presentation of talc granulomatosis three decades
after the last likely exposure. The history and imaging findings in a chronic smoker were initially
strongly suggestive of malignant disease, and we recommend that talc-induced lung disease is
considered in any patient with multiple scattered pulmonary lesions and a history of intravenous
drug use. Confirmation of the disease by biopsy is essential, but unfortunately there are few
successful proven management options for patients with worsening disease.
Introduction
Pulmonary talc granulomatosis is a rare disorder charac-
terized by the development of foreign body granuloma
secondary to talc exposure. Several case reports have doc-
umented the disease in known intravenous drug abusers
who present with respiratory symptoms. We present the
diagnosis in a patient with a remote history of intravenous
heroin use, and initial symptoms and imaging suggestive
of malignancy.
Case presentation
A 53-year-old man presented with increasing dyspnea and
a weight loss of 3 kg over a 4-month period. Past medical
history was significant for emphysema, seizure disorder
and hepatitis C. Medications included albuterol and
dilantin. The patient was unemployed and had a 35-pack/
year history of smoking. He also reported intravenous her-
oin abuse 30 years previously (undertaken for a period of
10 years).
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Laboratory results including complete blood count, renal
function and liver function tests were all within normal
limits. Human immunodeficiency virus (HIV) serology
was negative. A chest X-ray (Figure 1) showed an ill-
defined density close to the right heart border, and a com-
puted tomography (CT) scan (Figure 2) confirmed a 4.5 ×
2.2 cm opacity in the medial aspect of the right middle
lobe, with emphysematous changes and spiculated opaci-
ties in both lung fields suspicious for malignant spread. A
CT scan of the abdomen and pelvis was unremarkable.
The patient underwent autofluorescence bronchoscopy
and the visualized portions of the upper and lower air-
ways were widely patent with no abnormalities. Ultra-
sound of the mediastinum using ultrasonic
bronchofibervideoscope located the echodensity inferior
to the right hilum, and fine needle biopsy of this structure
was obtained via endobronchial ultrasound-guided trans-
bronchial needle aspiration. Biopsies were also obtained
from four further echodense areas suggestive of malignant
lesions involving both lungs.
The biopsy returned negative for malignancy, and histol-
ogy from the multiple sites showed bronchial epithelial
cells with a marked foreign body giant cell reaction and
associated polarizable birefringent foreign bodies
(Figures 3, 4 and 5). A diagnosis of talc granulomatosis
secondary to previous intravenous drug abuse was made.
The patient was discharged home and his dyspnea and
weight loss were attributed to worsening emphysema in
the setting of continued heavy smoking, superimposed on
talc granulomatosis, causing deteriorating lung infection.
Discussion
Talc, or hydrated magnesium silicate, is formed during the
breakdown of anthrophyllite rock. It has a wide array of
industrial uses, and for pharmacological purposes is uti-
lized as a binder in oral tablets to hold the medication
together.
Four types of pulmonary disease secondary to talc expo-
sure have been defined [1]: (i) talcosilicosis, (ii) talco-
asbestosis, (iii) talcosis and (iv) talc granulomatosis. The
first two are associated with occupational exposure, the
third with inhalation of pure talc, and the fourth in the
setting of intravenous drug addicts who inject tablets
intended for oral use.
It is probable that only a small percentage of intravenous
drug addicts frequently engage in this activity [2], and
medications associated with the disease include methyl-
phenidate, methadone and amphetamines. In addition to
drug abusers who inject these oral medications, talcosis
has also been reported secondary to cocaine sniffing in the
absence of any intravenous drug use [3].
Spiculated opacity suspicious for lung malignancy Figure 2
Spiculated opacity suspicious for lung malignancy. 
Maximum diameter 4.5 cm.
Ill-defined, mass-like density in the right middle lobe of the  lung Figure 1
Ill-defined, mass-like density in the right middle lobe 
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The exact pathophysiological mechanism of talc granulo-
matosis is unknown. Talc embolization results in an ini-
tial inflammatory arteritis, associated with a rapid influx
of neutrophils around the talc particle. Foreign body gran-
uloma later develops after migration of particles to the
surrounding perivascular and pulmonary interstitial tis-
sue.
This reaction to talc is highly variable, some patients
develop interstitial granulomas and others develop gran-
ulomas in the lumens of small pulmonary arteries (result-
ing in pulmonary hypertension). The carcinogenicity of
inhaled talc also remains controversial, with one study
finding no increase in the rate of lung cancer in employees
of a talc processing plant in New York over a 31-year
period [4].
Patients with talc granulomatosis can range from asymp-
tomatic to fulminant disease. Symptomatic patients typi-
cally present with non-specific complaints including
progressive exertional dyspnea, dry cough, or less typi-
cally, weight loss and night sweats. More serious presenta-
tions may involve adult respiratory distress syndrome or
progressive massive fibrosis [5]. Spontaneous pneumoth-
orax has also been reported as a presenting symptom [6].
Further cases of extrapulmonary disease have been docu-
mented in the eyes (talc retinopathy) [7], uterus [8] and
liver [9].
Physical examination is typically unremarkable, although
there may be bibasal crepitations in the presence of fibro-
sis. Laboratory values are also usually within normal lim-
its. Pulmonary function tests frequently show a reduction
in carbon monoxide diffusion.
The most common chest X-ray finding is widespread, 2 to
3 mm, well-defined nodules, often in the mid-lung [10].
Histology showing talc particles at a lower magnification Figure 5
Histology showing talc particles at a lower magnifica-
tion. Hematoxylin-eosin stain.
Histology showing talc particles Figure 3
Histology showing talc particles. Hematoxylin-eosin 
stain, magnification ×400.
Talc particles under polarized light Figure 4
Talc particles under polarized light. Magnification ×200.Journal of Medical Case Reports 2008, 2:225 http://www.jmedicalcasereports.com/content/2/1/225
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As the disease progresses, the nodules coalesce and mas-
sive fibrosis can occur. High-resolution CT may reveal a
diffuse ground-glass pattern with emphysema. One
review of CT findings in 12 patients with talc granuloma-
tosis found that the predominant abnormalities were
nodules and lower lobe panacinar emphysema (three
patients), diffuse fine nodular pattern (two patients), and
ground-glass attenuation (two patients). Emphysema was
seen in the remaining five patients [11].
The patient in our case had a relatively good baseline level
of health and had been free of drug use for 30 years. He
had no other hospitalizations or outpatient investigations
that had previously demonstrated the presence of any
abnormalities in his chest.
Differential diagnoses include: interstitial lung disease,
emphysema, sarcoidosis, pneumoconiosis, tuberculosis
and opportunistic infections such as pneumocystis and
cytomegalovirus pneumonia. Neoplasms, such as bron-
cho-alveolar carcinoma and lymphoid malignancy, must
also be excluded. Any patient with risk factors should be
tested for HIV.
Bronchoscopy and biopsy are necessary for definitive
diagnosis. Early diagnosis is paramount in order to avoid
misdiagnosis. A single case report of a 38-year-old man
with HIV reported empirical treatment for Pneumocystis
jiroveci in a patient who subsequently died before the cor-
rect diagnosis was made [12].
Broncho-alveolar lavage will usually reveal lymphocytosis
with a predominance of CD8 lymphocytes. The fluid
appears crystalline under polarized light. Transbronchial
or open-lung biopsy can be utilized to obtain a tissue
specimen. Histology will reveal foreign body giant cell
reaction with birefringent plate-like talc crystals.
There are no established treatments for talc granulomato-
sis. Patients must stop intravenous drug and any tobacco
use. Successful steroid use has been reported in a 24-year-
old man who responded to treatment with 60 mg of pred-
nisone daily [13], but further data are lacking. Associated
pulmonary hypertension should be treated with vasodila-
tors. Lung transplantation is reserved as a last resort for
patients with end-stage disease. Unfortunately most
patients have poor outcomes and experience a progressive
decline in pulmonary function. One 10-year follow-up of
six patients described an irreversible progression of radio-
graphic abnormalities [5].
Conclusion
This case demonstrates a rare presentation of talc granulo-
matosis three decades after the last likely exposure. The
history and imaging findings in a chronic smoker were
initially strongly suggestive of malignant disease, and we
recommend that talc-induced lung disease is considered
in any patient with multiple scattered pulmonary lesions
and a history of intravenous drug use. Confirmation of
the disease by biopsy is essential, but unfortunately there
are few successful proven management options for
patients with worsening disease.
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